<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87456">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02047851</url>
  </required_header>
  <id_info>
    <org_study_id>H-1-2013-122</org_study_id>
    <nct_id>NCT02047851</nct_id>
  </id_info>
  <brief_title>Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis</brief_title>
  <official_title>Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aage Bangs Fond</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <oversight_info>
    <authority>Denmark: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether acupuncture is helpful for patients with
      joint pain associated with psoriasis
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain measured on the VAS</measure>
    <time_frame>From day 0 to day 60 of the trial</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients will record their level of pain in a journal each day, ranging from 0 to 10 where 0 is no pain and 10 is worst possible pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in life quality measured with the DLQI (Dermatology Life Quality Index)</measure>
    <time_frame>From day 0 to day 60 of the study period</time_frame>
    <safety_issue>No</safety_issue>
    <description>On day 0, 30 and 60 the patients will fill out a simple questionnaire with 10 questions concerning their life quality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Approvement in skin lesions</measure>
    <time_frame>From day 0 to day 60 of the study period</time_frame>
    <safety_issue>No</safety_issue>
    <description>At each of the 3 control visits the patients will be asked if their psoriatic skin lesions have become better from the acupuncture, and if they say yes, how much better? Minimal improvement, moderate improvement og big improvement?</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Psoriasis</condition>
  <condition>Arthralgia</condition>
  <arm_group>
    <arm_group_label>Acupuncture in active points</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will receive real acupuncture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acupuncture in non-active points</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients in this group will receive acupuncture, but in non-active points</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment, just observation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will receive no treatment and will only be observed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Patients are randomized to real acupuncture or sham acupuncture if they are in the intervention group</description>
    <arm_group_label>Acupuncture in active points</arm_group_label>
    <arm_group_label>Acupuncture in non-active points</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Plaque psoriasis

          -  Pain from at least two peripheral joints and/or inflammatory back pain

          -  No or stabile treatment of the psoriasis the last 3 months

          -  No or stabile pain treatment the last 3 months

          -  Oral and written information given

          -  Written consent signed

        Exclusion Criteria:

          -  Arthritis with Ultrasound verified intra articular fluid og clinical verified joint
             swelling

          -  Pregnancy og breastfeeding

          -  Previous treatments with acupuncture

          -  Treatment with anticoagulants (vitamin K-antagonists, low molecular weight heparin,
             unfractionated heparin, direct thrombin inhibitors, direct factor Xa inhibitors)

          -  Unwilling to follow protocol
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The departement of allergy and dermatology, Gentofte Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kristiane Engebretsen</last_name>
      <phone>004591108344</phone>
      <email>kristiane_engebretsen@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Annesofie Faurschou, MD, PhD</last_name>
      <email>afau16@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Kristiane Engebretsen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annesofie Faurschou, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 26, 2014</lastchanged_date>
  <firstreceived_date>January 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gentofte, Copenhagen</investigator_affiliation>
    <investigator_full_name>Annesofie Faurschou</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthralgia</mesh_term>
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
